26 November 2012

Bayer HealthCare acquires Toronto-based Radimetrics

- Radimetrics develops healthcare software - eXposure™
- Founded in 2009, employees in Toronto and Scotland 

Leverkusen - 26 November 2012 – Bayer HealthCare announced today that it has entered into a definitive acquisition agreement with the principals of privately-held Radimetrics Inc., to purchase all shares of the company. Toronto-based Radimetrics Inc. develops healthcare software and has introduced software to accurately measure a patient’s radiation exposure over the course of multiple imaging procedures. The software, eXposure™, is also a very powerful quality assurance and improvement platform that includes the ability to define and manage scanner protocols. Financial details on the agreement were not disclosed.

“This is a strategic acquisition as Bayer moves its Radiology & Interventional business forward to be the end-to-end provider of products, solutions and service for the radiology customer,” said Alan Main, Head of Bayer HealthCare’s Medical Care division.

Radimetrics employees in Toronto and Scotland will become employees of the Bayer group, expanding the company’s existing informatics group in the Radiology & Interventionals organization. Founded in 2009, Radimetrics’ flagship product, eXposure, integrates with existing imaging and patient information technology storage systems (i.e., PACS/RIS(1)) to provide a single system for tracking patient radiation exposure across imaging modalities. eXposure is used in many commercial hospital groups and other medical delivery organizations in North America and a growing number in Europe.

According to Alan Main, “Bayer Healthcare’s Radiology & Interventional is well positioned as a leader in the industry to accelerate broad market adoption of eXposure to new customers who are looking for ways to better leverage technology and improve radiation dose monitoring accuracy. The combined strengths of our informatics platforms will drive future innovative customer solutions.”

Gregory Couch, President and founder of Radimetrics, said, “Today’s agreement is a new chapter in a great alliance which began earlier this year. Radimetrics has been committed to developing innovative software that focuses on patient safety, quality and productivity in medical imaging. We feel that Bayer Radiology & Interventional is well positioned to continue this commitment and I’m excited to join the organization and work to make this happen.”

Much more than just dose monitoring software, eXposure™ provides an extraordinary set of features such as automated dose reference level monitoring, flexible dashboard-style reporting, and protocol management all in an easy-to-use web-based application.

The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 17.2 billion (2011), is one of the world’s leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare has a global workforce of 55,700 employees (Dec 31, 2011) and is represented in more than 100 countries. 

Source: Bayer HealthCare